Detalhe da pesquisa
1.
xCT knockdown in human breast cancer cells delays onset of cancer-induced bone pain.
Mol Pain
; 15: 1744806918822185, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30799686
2.
Functional effects of TrkA inhibition on system xC--mediated glutamate release and cancer-induced bone pain.
Mol Pain
; 14: 1744806918776467, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29761734
3.
Oxidative stress and cancer pain.
Can J Physiol Pharmacol
; 91(1): 31-7, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23368277
4.
Response to pregabalin and progesterone differs in male and female rat models of neuropathic and cancer pain.
Can J Pain
; 4(1): 39-58, 2020 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-33987485
5.
Activation of hippocampal microglia in a murine model of cancer-induced pain.
J Pain Res
; 12: 1003-1016, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30936739
6.
Preparation of tetrazine-containing [2 + 1] complexes of 99mTc and in vivo targeting using bioorthogonal inverse electron demand Diels-Alder chemistry.
Dalton Trans
; 46(42): 14691-14699, 2017 Oct 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-28640297
7.
Behavioural Effects of Using Sulfasalazine to Inhibit Glutamate Released by Cancer Cells: A Novel target for Cancer-Induced Depression.
Sci Rep
; 7: 41382, 2017 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-28120908
8.
Chronic Inhibition of STAT3/STAT5 in Treatment-Resistant Human Breast Cancer Cell Subtypes: Convergence on the ROS/SUMO Pathway and Its Effects on xCT Expression and System xc- Activity.
PLoS One
; 11(8): e0161202, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27513743
9.
Inhibition of breast cancer-cell glutamate release with sulfasalazine limits cancer-induced bone pain.
Pain
; 155(1): 28-36, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23999057